Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)

SHE:300760 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	17,711	16,644	18,787	23,186	15,361	15,865
Cash & Short-Term Investments	17,711	16,644	18,787	23,186	15,361	15,865
Cash Growth	-16.43%	-11.41%	-18.97%	50.94%	-3.17%	11.15%
Accounts Receivable	3,482	3,226	3,297	2,661	1,790	1,539
Other Receivables	224.86	205.53	195.1	149.11	126.04	279.03
Receivables	3,751	3,475	3,534	2,842	1,943	1,842
Inventory	5,173	4,757	3,979	4,025	3,565	3,617
Prepaid Expenses	-	59.71	60.57	92.31	58.1	123.87
Other Current Assets	674.5	709.96	515.29	461.19	407.58	183.29
Total Current Assets	27,310	25,647	26,875	30,606	21,335	21,632
Property, Plant & Equipment	10,132	10,035	8,221	6,290	5,131	4,129
Long-Term Investments	402.28	395.37	3,087	1,617	4,026	4,026
Goodwill	11,220	11,093	5,062	4,403	4,218	1,225
Other Intangible Assets	6,543	6,723	2,225	1,977	2,061	1,145
Long-Term Accounts Receivable	22.81	22.86	10.94	25.28	34.55	3.32
Long-Term Deferred Tax Assets	1,548	1,697	1,313	755.08	596.43	501.89
Long-Term Deferred Charges	483.97	406	417.23	379.45	224.24	204.16
Other Long-Term Assets	702.59	504.29	604	590.95	376.65	337.3
Total Assets	58,365	56,644	47,940	46,745	38,103	33,306
Accounts Payable	3,134	2,793	2,690	2,291	2,281	1,500
Accrued Expenses	2,411	3,253	3,049	3,136	2,428	2,063
Short-Term Debt	5.71	5.4	7.75	-	-	-
Current Portion of Long-Term Debt	112.17	1.16	0.43	-	-	-
Current Portion of Leases	-	114.27	104.3	97.22	85.08	-
Current Income Taxes Payable	454.39	205.43	471.65	287.22	256.75	136.31
Current Unearned Revenue	2,226	2,166	1,974	4,143	2,408	3,293
Other Current Liabilities	2,398	1,889	1,804	1,816	1,170	1,244
Total Current Liabilities	10,741	10,427	10,103	11,770	8,629	8,236
Long-Term Debt	0.34	0.34	1.38	-	-	-
Long-Term Leases	182.06	177.31	181.07	139.31	152.15	-
Long-Term Unearned Revenue	145.18	127	109.31	92.94	105.09	156.79
Long-Term Deferred Tax Liabilities	806.2	808.7	168.36	183.13	200.44	46.62
Other Long-Term Liabilities	2,932	4,345	4,031	2,561	2,048	1,576
Total Liabilities	14,807	15,885	14,594	14,746	11,135	10,016
Common Stock	1,212	1,212	1,212	1,212	1,216	1,216
Additional Paid-In Capital	6,735	6,752	7,091	7,509	8,153	8,153
Retained Earnings	30,856	28,229	25,288	24,369	18,994	14,032
Treasury Stock	-337.77	-337.77	-663.28	-999.99	-999.99	-
Comprehensive Income & Other	124.95	1.51	157.27	-109.07	-409.74	-122.58
Total Common Equity	38,590	35,856	33,085	31,981	26,953	23,278
Minority Interest	4,968	4,902	260.65	18.29	15.24	12.75
Shareholders' Equity	43,558	40,758	33,346	31,999	26,968	23,290
Total Liabilities & Equity	58,365	56,644	47,940	46,745	38,103	33,306
Total Debt	300.28	298.49	294.93	236.52	237.24	-
Net Cash (Debt)	17,411	16,346	18,492	22,949	15,124	15,865
Net Cash Growth	-16.74%	-11.61%	-19.42%	51.74%	-4.67%	11.15%
Net Cash Per Share	14.37	13.49	15.26	18.96	12.45	13.05
Filing Date Shares Outstanding	1,211	1,210	1,214	1,209	1,213	1,216
Total Common Shares Outstanding	1,211	1,210	1,214	1,209	1,213	1,216
Working Capital	16,569	15,219	16,773	18,836	12,706	13,395
Book Value Per Share	31.85	29.64	27.25	26.44	22.23	19.15
Tangible Book Value	20,827	18,040	25,799	25,601	20,673	20,908
Tangible Book Value Per Share	17.19	14.91	21.25	21.17	17.05	17.20
Land	-	5,978	4,799	3,662	3,259	2,876
Machinery	-	4,149	3,283	2,822	2,366	1,924
Construction In Progress	-	2,675	2,461	1,803	1,126	929.84

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.